Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies

• Andrew Wallace,
• Ryan Jones,
• Richard Bourgon,
• Guang-Yu Yang,
• Amy A Lo,
• Daniel Oreper,
• Nicolas Lounsbury,
• Charles Havnar,
• Ximo Pechuan-Jorge,
• Thomas D Wu,
• Katrina Krogh,
• Oliver A Zill

Affiliations

Andrew Wallace

Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA

Ryan Jones

Department of Pathology, Northwestern University, Chicago, Illinois, USA

Richard Bourgon

Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA

Guang-Yu Yang

Department of Pathology, Northwestern University, Chicago, Illinois, USA

Amy A Lo

Department of Research Pathology, Genentech Inc, South San Francisco, California, USA

Daniel Oreper

Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA

Nicolas Lounsbury

Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA

Charles Havnar

Department of Research Pathology, Genentech Inc, South San Francisco, California, USA

Ximo Pechuan-Jorge

Department of Cancer Immunology, Genentech Inc, South San Francisco, California, USA

Thomas D Wu

Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA

Katrina Krogh

Department of Pathology, Northwestern University, Chicago, Illinois, USA

Oliver A Zill

Department of Oncology Bioinformatics, Genentech Inc, South San Francisco, California, USA